SNX9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.493400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.688800E-01
Normal-vs-Stage2
8.905800E-01
Normal-vs-Stage3
9.934800E-01
Normal-vs-Stage4
4.850800E-01
Stage1-vs-Stage2
2.518000E-01
Stage1-vs-Stage3
5.711000E-01
Stage1-vs-Stage4
1.381780E-01
Stage2-vs-Stage3
8.880000E-01
Stage2-vs-Stage4
3.821600E-01
Stage3-vs-Stage4
5.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.829400E-01
Normal-vs-AfricanAmerican
5.405000E-01
Normal-vs-Asian
9.013200E-01
Caucasian-vs-AfricanAmerican
1.551420E-01
Caucasian-vs-Asian
7.922000E-01
AfricanAmerican-vs-Asian
3.197000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.732600E-01
Normal-vs-Female
8.419400E-01
Male-vs-Female
4.055200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.663200E-01
Normal-vs-Age(41-60Yrs)
5.792800E-01
Normal-vs-Age(61-80Yrs)
9.173200E-01
Normal-vs-Age(81-100Yrs)
6.620400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.422600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.542200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.958000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.136100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.544100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.479000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.164200E-01
Normal-vs-Daily Drinker
4.645400E-01
Normal-vs-Weekly Drinker
8.507000E-01
Normal-vs-Occasional Drinker
8.008400E-01
Normal-vs-Social Drinker
9.352800E-01
Non Drinker-vs-Daily Drinker
3.225200E-01
Non Drinker-vs-Weekly Drinker
4.343400E-01
Non Drinker-vs-Occasional Drinker
9.775200E-01
Non Drinker-vs-Social Drinker
5.547600E-01
Daily Drinker-vs-Weekly Drinker
1.116230E-01
Daily Drinker-vs-Occasional Drinker
3.234600E-01
Daily Drinker-vs-Social Drinker
1.605600E-01
Weekly Drinker-vs-Occasional Drinker
4.492000E-01
Weekly Drinker-vs-Social Drinker
8.654800E-01
Occasional Drinker-vs-Social Drinker
5.776000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.325200E-01
Normal-vs-Grade 2
3.968200E-02
Normal-vs-Grade 3
5.150100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.903500E-02
Grade 1-vs-Grade 3
3.213000E-01
Grade 1-vs-Grade 4
2.325200E-01
Grade 2-vs-Grade 3
2.486400E-01
Grade 2-vs-Grade 4
3.968200E-02
Grade 3-vs-Grade 4
5.150100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.281200E-01
Normal-vs-NonDiabetic
9.896000E-01
Diabetic-vs-NonDiabetic
5.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.794000E-01
Normal-vs-NoPancreatitis
9.460400E-01
Pancreatitis-vs-NoPancreatitis
8.580800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.790400E-01
Normal-vs-N1
8.793600E-01
N0-vs-N1
5.377600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.308600E-01
Normal-vs-TP53-NonMutant
4.359600E-01
TP53-Mutant-vs-TP53-NonMutant
2.055600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
